COLOPLAST-B (CBHD.DE) Fundamental Analysis & Valuation

FRA:CBHD • DK0060448595

Current stock price

60.3 EUR
+0.44 (+0.74%)
Last:

This CBHD.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CBHD.DE Profitability Analysis

1.1 Basic Checks

  • CBHD had positive earnings in the past year.
  • In the past year CBHD had a positive cash flow from operations.
  • CBHD had positive earnings in each of the past 5 years.
  • In the past 5 years CBHD always reported a positive cash flow from operatings.
CBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFCBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • CBHD has a better Return On Assets (8.17%) than 87.69% of its industry peers.
  • CBHD has a Return On Equity of 28.90%. This is amongst the best in the industry. CBHD outperforms 93.85% of its industry peers.
  • CBHD has a Return On Invested Capital of 12.85%. This is amongst the best in the industry. CBHD outperforms 87.69% of its industry peers.
  • CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 10.72%.
Industry RankSector Rank
ROA 8.17%
ROE 28.9%
ROIC 12.85%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
CBHD.DE Yearly ROA, ROE, ROICCBHD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • CBHD has a Profit Margin of 14.30%. This is amongst the best in the industry. CBHD outperforms 81.54% of its industry peers.
  • In the last couple of years the Profit Margin of CBHD has declined.
  • CBHD has a Operating Margin of 27.28%. This is amongst the best in the industry. CBHD outperforms 93.85% of its industry peers.
  • CBHD's Operating Margin has declined in the last couple of years.
  • CBHD's Gross Margin of 67.87% is fine compared to the rest of the industry. CBHD outperforms 75.38% of its industry peers.
  • In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
Industry RankSector Rank
OM 27.28%
PM (TTM) 14.3%
GM 67.87%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
CBHD.DE Yearly Profit, Operating, Gross MarginsCBHD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. CBHD.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
  • Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
  • Compared to 5 years ago, CBHD has more shares outstanding
  • The debt/assets ratio for CBHD has been reduced compared to a year ago.
CBHD.DE Yearly Shares OutstandingCBHD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CBHD.DE Yearly Total Debt VS Total AssetsCBHD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.19 indicates that CBHD is not in any danger for bankruptcy at the moment.
  • CBHD's Altman-Z score of 3.19 is fine compared to the rest of the industry. CBHD outperforms 66.15% of its industry peers.
  • The Debt to FCF ratio of CBHD is 4.70, which is a neutral value as it means it would take CBHD, 4.70 years of fcf income to pay off all of its debts.
  • CBHD has a Debt to FCF ratio (4.70) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.55 is on the high side and indicates that CBHD has dependencies on debt financing.
  • The Debt to Equity ratio of CBHD (1.55) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 4.7
Altman-Z 3.19
ROIC/WACC2.2
WACC5.85%
CBHD.DE Yearly LT Debt VS Equity VS FCFCBHD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • CBHD has a Current Ratio of 1.30. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.30, CBHD is doing worse than 63.08% of the companies in the same industry.
  • CBHD has a Quick Ratio of 1.30. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, CBHD is doing worse than 67.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.81
CBHD.DE Yearly Current Assets VS Current LiabilitesCBHD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. CBHD.DE Growth Analysis

3.1 Past

  • The earnings per share for CBHD have decreased strongly by -13.16% in the last year.
  • The Earnings Per Share has been decreasing by -2.02% on average over the past years.
  • CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 1.61%.
  • CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%

3.2 Future

  • CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.92% yearly.
  • CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.68% yearly.
EPS Next Y44.54%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
EPS Next 5Y15.92%
Revenue Next Year3.43%
Revenue Next 2Y5.25%
Revenue Next 3Y5.8%
Revenue Next 5Y6.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CBHD.DE Yearly Revenue VS EstimatesCBHD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
CBHD.DE Yearly EPS VS EstimatesCBHD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

6

4. CBHD.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.65, the valuation of CBHD can be described as rather expensive.
  • CBHD's Price/Earnings ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 66.15% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (25.70), we can say CBHD is valued inline with the index average.
  • The Price/Forward Earnings ratio is 16.11, which indicates a correct valuation of CBHD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 70.77% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, CBHD is valued a bit cheaper.
Industry RankSector Rank
PE 23.65
Fwd PE 16.11
CBHD.DE Price Earnings VS Forward Price EarningsCBHD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CBHD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 64.62% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CBHD is valued cheaply inside the industry as 81.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.74
EV/EBITDA 13
CBHD.DE Per share dataCBHD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CBHD has a very decent profitability rating, which may justify a higher PE ratio.
  • CBHD's earnings are expected to grow with 19.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)N/A
EPS Next 2Y25.48%
EPS Next 3Y19.56%

7

5. CBHD.DE Dividend Analysis

5.1 Amount

  • CBHD has a Yearly Dividend Yield of 5.23%, which is a nice return.
  • In the last 3 months the price of CBHD has falen by -20.05%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.02. CBHD pays more dividend than 98.46% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CBHD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.23%

5.2 History

  • The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
CBHD.DE Yearly Dividends per shareCBHD.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

5.3 Sustainability

  • CBHD pays out 129.96% of its income as dividend. This is not a sustainable payout ratio.
  • CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP129.96%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
CBHD.DE Yearly Income VS Free CF VS DividendCBHD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
CBHD.DE Dividend Payout.CBHD.DE Dividend Payout, showing the Payout Ratio.CBHD.DE Dividend Payout.PayoutRetained Earnings

CBHD.DE Fundamentals: All Metrics, Ratios and Statistics

COLOPLAST-B

FRA:CBHD (3/13/2026, 7:00:00 PM)

60.3

+0.44 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06
Earnings (Next)05-12
Inst Owners29.4%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap12.68B
Revenue(TTM)27.89B
Net Income(TTM)3.99B
Analysts66.67
Price Target77.93 (29.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.23%
Yearly Dividend2.94
Dividend Growth(5Y)5.3%
DP129.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.23%
Min EPS beat(2)-26.06%
Max EPS beat(2)1.6%
EPS beat(4)1
Avg EPS beat(4)-15.95%
Min EPS beat(4)-26.06%
Max EPS beat(4)1.6%
EPS beat(8)1
Avg EPS beat(8)-11.35%
EPS beat(12)1
Avg EPS beat(12)-9.84%
EPS beat(16)2
Avg EPS beat(16)-9.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.24%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.49%
Revenue beat(12)1
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)-11.71%
PT rev (3m)-15.85%
EPS NQ rev (1m)-7.76%
EPS NQ rev (3m)-10.99%
EPS NY rev (1m)-1.61%
EPS NY rev (3m)-1.59%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.29%
Revenue NY rev (1m)-1.39%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE 23.65
Fwd PE 16.11
P/S 3.4
P/FCF 17.74
P/OCF 13.78
P/B 6.86
P/tB N/A
EV/EBITDA 13
EPS(TTM)2.55
EY4.23%
EPS(NY)3.74
Fwd EY6.21%
FCF(TTM)3.4
FCFY5.64%
OCF(TTM)4.37
OCFY7.25%
SpS17.76
BVpS8.79
TBVpS-10.42
PEG (NY)0.53
PEG (5Y)N/A
Graham Number22.46
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 28.9%
ROCE 18.62%
ROIC 12.85%
ROICexc 13.21%
ROICexgc 54.89%
OM 27.28%
PM (TTM) 14.3%
GM 67.87%
FCFM 19.14%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-ScoreN/A
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.55
Debt/FCF 4.7
Debt/EBITDA 2.36
Cap/Depr 104.29%
Cap/Sales 5.5%
Interest Coverage 12.72
Cash Conversion 75.69%
Profit Quality 133.82%
Current Ratio 1.3
Quick Ratio 0.81
Altman-Z 3.19
F-ScoreN/A
WACC5.85%
ROIC/WACC2.2
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.16%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%26.79%
EPS Next Y44.54%
EPS Next 2Y25.48%
EPS Next 3Y19.56%
EPS Next 5Y15.92%
Revenue 1Y (TTM)1.61%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.24%
Revenue Next Year3.43%
Revenue Next 2Y5.25%
Revenue Next 3Y5.8%
Revenue Next 5Y6.68%
EBIT growth 1Y3.15%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year25.11%
EBIT Next 3Y13.25%
EBIT Next 5Y11.53%
FCF growth 1Y24.69%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y24.41%
OCF growth 3Y9.24%
OCF growth 5Y6.9%

COLOPLAST-B / CBHD.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.


Can you provide the valuation status for COLOPLAST-B?

ChartMill assigns a valuation rating of 6 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for COLOPLAST-B?

COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.


How financially healthy is COLOPLAST-B?

The financial health rating of COLOPLAST-B (CBHD.DE) is 4 / 10.


What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?

The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 44.54% in the next year.